Daniel M Junius Idexx Laboratories Inc (IDXX) insider trading activity

IDXX Quotes by TradingView

Daniel M Junius is Director of IDEXX LABORATORIES INC . Currently has a direct ownership of 3,042 shares of IDXX, which is worth approximately $1.27 Million. The most recent transaction as insider was on Jan 30, 2024, when has been sold 14 shares (Common Stock) at a price of $521.03 per share, resulting in proceeds of $7,294. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.04K
0% 3M change
0.46% 12M change
Total Value Held $1.27 Million

DANIEL M JUNIUS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 30 2024
BUY
Grant, award, or other acquisition
$7,294 $521.03 p/Share
14 Added 0.46%
3,042 Common Stock
Oct 30 2023
BUY
Grant, award, or other acquisition
$7,531 $396.39 p/Share
19 Added 0.62%
3,028 Common Stock
Jul 28 2023
BUY
Grant, award, or other acquisition
$7,738 $552.78 p/Share
14 Added 0.46%
3,009 Common Stock
Apr 28 2023
BUY
Grant, award, or other acquisition
$6,398 $492.16 p/Share
13 Added 0.43%
2,995 Common Stock
Feb 16 2023
SELL
Open market or private sale
$1,119,044 $511.68 p/Share
2,187 Reduced 42.31%
2,982 Common Stock
Feb 16 2023
BUY
Exercise of conversion of derivative security
$451,877 $206.62 p/Share
2,187 Added 29.73%
5,169 Common Stock
Jan 30 2023
BUY
Grant, award, or other acquisition
$6,761 $482.95 p/Share
14 Added 0.47%
2,982 Common Stock
Dec 05 2022
SELL
Open market or private sale
$1,294,275 $424.91 p/Share
3,046 Reduced 50.65%
2,968 Common Stock
Dec 05 2022
BUY
Exercise of conversion of derivative security
$488,212 $160.28 p/Share
3,046 Added 33.62%
6,014 Common Stock
Oct 28 2022
BUY
Grant, award, or other acquisition
$6,557 $364.28 p/Share
18 Added 0.6%
2,968 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
$6,387 $399.18 p/Share
16 Added 0.54%
2,950 Common Stock
Apr 29 2022
BUY
Grant, award, or other acquisition
$6,457 $430.48 p/Share
15 Added 0.51%
2,934 Common Stock
Jan 28 2022
BUY
Grant, award, or other acquisition
$6,358 $489.05 p/Share
13 Added 0.44%
2,919 Common Stock
Oct 29 2021
BUY
Grant, award, or other acquisition
$6,661 $666.14 p/Share
10 Added 0.34%
2,906 Common Stock
Aug 10 2021
SELL
Open market or private sale
$1,632,351 $679.58 p/Share
2,402 Reduced 45.34%
2,896 Common Stock
Aug 10 2021
BUY
Exercise of conversion of derivative security
$204,170 $85.0 p/Share
2,402 Added 31.19%
5,298 Common Stock
Jul 30 2021
BUY
Grant, award, or other acquisition
$6,785 $678.53 p/Share
10 Added 0.34%
2,896 Common Stock
May 21 2021
SELL
Open market or private sale
$1,348,925 $539.57 p/Share
2,500 Reduced 46.42%
2,886 Common Stock
May 21 2021
BUY
Exercise of conversion of derivative security
$212,500 $85.0 p/Share
2,500 Added 31.7%
5,386 Common Stock
Apr 30 2021
BUY
Grant, award, or other acquisition
$6,039 $548.99 p/Share
11 Added 0.38%
2,886 Common Stock
Feb 22 2021
SELL
Open market or private sale
$1,022,794 $538.88 p/Share
1,898 Reduced 39.77%
2,875 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$156,148 $82.27 p/Share
1,898 Added 28.45%
4,773 Common Stock
Jan 29 2021
BUY
Grant, award, or other acquisition
$6,223 $478.68 p/Share
13 Added 0.45%
2,875 Common Stock
Oct 30 2020
BUY
Grant, award, or other acquisition
$6,372 $424.82 p/Share
15 Added 0.52%
2,862 Common Stock

Also insider at

GLYC
GLYCOMIMETICS INC Healthcare
DMJ

Daniel M Junius

Director
Westbrook, ME

Track Institutional and Insider Activities on IDXX

Follow IDEXX LABORATORIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDXX shares.

Notify only if

Insider Trading

Get notified when an Idexx Laboratories Inc insider buys or sells IDXX shares.

Notify only if

News

Receive news related to IDEXX LABORATORIES INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IDXX